Form 8-K - Current report:
SEC Accession No. 0001193125-24-170634
Filing Date
2024-06-27
Accepted
2024-06-27 16:28:01
Documents
15
Period of Report
2024-06-25
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d839852d8k.htm   iXBRL 8-K 42074
2 EX-10.1 d839852dex101.htm EX-10.1 106759
6 GRAPHIC g839852g0626231722996.jpg GRAPHIC 4172
  Complete submission text file 0001193125-24-170634.txt   312328

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mdgl-20240625.xsd EX-101.SCH 2872
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE mdgl-20240625_lab.xml EX-101.LAB 18758
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mdgl-20240625_pre.xml EX-101.PRE 11725
18 EXTRACTED XBRL INSTANCE DOCUMENT d839852d8k_htm.xml XML 3802
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Filer) CIK: 0001157601 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33277 | Film No.: 241079645
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)